Connect With the Global Treg Community
As the Treg field moves closer to commercialization, organizations are looking for ways to strengthen their competitive position, identify the right partners, and better understand where the market is heading.
The 9th Treg-Directed Therapies Summit provides access to a highly focused audience of leaders actively advancing Treg research and development. By bringing together the organizations shaping clinical, translational, and commercial progress, the meeting creates a valuable opportunity to position your services at the center of Treg advancement.
Whether your organization supports cell therapy development, patient identification, biomarker discovery, manufacturing, regulatory strategy, or clinical execution, this is a rare opportunity to engage directly with the community driving the next generation of Treg therapies and build relationships with decision-makers actively investing in the future of the field.
What to Expect?
Meet New Clients
Engage directly with companies developing Treg therapies and Treg-modulating approaches seeking specialist expertise and technology solutions.
Center Yourself in Immune Tolerance Innovation
Raise visibility amongst senior biotech leaders, pharma stakeholders, and investors evaluating the future of immune tolerance.
Demonstrate Your Expertise
Position your organization as a trusted partner through thought leadership, exhibition opportunities, and strategic networking.
Gain Market Intelligence
Learn about emerging challenges, competitive dynamics and investment trends influencing the next generation of Treg therapies.
Key Interest Areas
As Treg therapies progress towards clinical and commercial maturity, organizations are increasingly investing in technologies and partnerships that can improve persistence, potency assessment, product characterization, translational understanding, and manufacturing scalability.
Our attendees are looking for service and solution providers with capabilities in the below areas, including but not limited to:
Preclinical Models & Translational Research
Biomarker Discovery & Validation
Potency Assays & Analytical Development
Cell Characterization Technologies
Genomics & Epigenetics
Sequencing & Bioinformatics
Cell Processing & Automation
Gene Engineering & Viral Vector Technologies
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Presenting Opportunities
Share technical expertise through presentations, workshops, and panel discussions.
Exhibition Space
Build visibility and generate qualified commercial conversations.
Hosted Networking
Facilitate high-value interactions with decision-makers and scientific leaders.
Thought Leadership Panels
Contribute expertise to discussions shaping the future of Treg development.
Branding Packages
Maximize awareness through digital, print, and on-site promotion.
Bespoke Experiences
Create tailored opportunities such as receptions, dinners, and private meetings.
Full Delegate List
Identify key prospects and plan conversations ahead of the event.
Competitive Insights
Stay informed on the latest scientific, clinical, and commercial developments across the Treg landscape.
Hear What Our Past Sponsors Have to Say
Very high quality and breadth of presentations.
Barinthus Biotherapeutics, 2024 Sponsor
The line-up for the presentations was very good.
Nanotein Technologies, Inc., 2024 Sponsor
The size of the venue was appropriate and the presentation of clinical data was particularly valuable.
Revolo Biotherapeutics, 2025 Sponsor
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at [email protected] if you would like to get involved and discuss a bespoke package suited to your needs.
Malik Mellal
Partnerships Director